StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Total Current Assets by Quarter

Total Current Assets ($M)

QuarterlyAnnual

Novartis Total Current Assets: $28,747M in Q3 2026, up 1.9% from a year earlier.

Latest, Q3 2026
28,747
Period ended Sep 30, 2026
Change on a year earlier
+1.9%
28,198 in Q3 2025
History
35 quarters
Since Q4 2016
Sources
34
Documents cited below

Where the Q3 2026 figure comes from

“|| Total current assets | 28 747 | 30 460”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Current Assets ($M)Year on yearSource
Q3 2026Sep 30, 202628,747+1.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202627,351+5.4%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 202626,607+6.0%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202530,460+2.5%Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Q3 2025Sep 30, 202528,198-9.8%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202525,939+1.0%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 202525,108-5.1%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202429,704-2.5%Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗
Q3 2024Sep 30, 202431,264-31.5%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202425,693-23.3%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 202426,447-17.6%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202330,481-17.4%Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗
Q3 2023Sep 30, 202345,660+23.6%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202333,493-12.2%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 202332,114-13.8%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202236,910-19.3%Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗

Cite this data

StockData. (2026). Novartis Total Current Assets ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-curr-assets

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.